April 9, 2025: MaaT Pharma reports safety interim analysis from trial of microbiome therapy – Clinical Trials Arena

Date : April 9, 2025

[image_with_animation image_url=”15388″ animation=”Fade In” hover_animation=”none” alignment=”center” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.clinicaltrialsarena.com/newsletters/maat-interim-analysis-trial/?_hsenc=p2ANqtz-85onXwBQb96Po2LxcnTSTRtwTFHAkTOCQldtn6ouDd4n-FwqVGh_giTAiw2Nbc42YpdWynhC01NF5hGbcFVJS6G1ELW4GDWHuWqYxalkLB2aKm9TQ&_hsmi=107529468&utm_campaign=type3_Clinical%20Trials%20Arena-market&utm_medium=email&utm_content=Other_Daily_News_Articles&utm_source=email_NS”]